BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Johnson & Johnson (JNJ) Announced 10 New Approval Applications with $1 Billion Revenue Potential Each     5/21/2015
ASCO’s Most Important Abstracts: BioSpace (DHX)’s Cheat Sheet for You     5/21/2015
World's Richest Doctor Banks Another $100 Million for Cancer-Focused Startup NantBioscience     5/15/2015
BioSpace (DHX) Temperature Poll: Will AbbVie (ABBV), Genentech (RHHBY)’s New Cancer Drug Be a Game Changer?     5/13/2015
Bolstering Cancer Strategy, German Biotech BioNTech and Eli Lilly (LLY) Ink $360 Million Research Deal     5/12/2015
Amgen (AMGN)’s T-Vec Cancer Therapy Gets FDA Panel OK     5/4/2015
Prior to FDA Vote, Advisory Committee Cites Study Bias Concerns Over Amgen (AMGN) Cancer Vaccine     4/29/2015
EXCLUSIVE: Navidea (NAVB) CEO Tells BioSpace (DHX) New Cancer Treatment Will See More Trial Data in 2015     4/29/2015
EXCLUSIVE: Jounce CEO Says Funding Aims for Trials Next Year, Will Hire 10     4/27/2015
Celgene (CELG) Slaps Down $450 Million Upfront for AstraZeneca PLC (AZN)'s Prized Immunotherapy Blood Cancer Drug     4/24/2015
Innate Pharma (IPH.PA ) Strikes Cancer Pact Worth $1.275 Billion With Pharma Giant AstraZeneca PLC (AZN)     4/24/2015
Pfizer (PFE)'s New Leukemia Drug Meets Hematologic Remission Endpoint in Phase III Study     4/22/2015
Novartis AG (NVS) Taps Cancer Guru to Head Boston R&D Group That Specializes in Immuno-Oncology     4/22/2015
CAR-T Cell Companies Juno Therapeutics (JUNO), Kite Pharma (KITE), and ZIOPHARM, Inc. Get Stock Jitters on Disappointing Novartis AG (NVS) Trial News     4/22/2015
Investors Suddenly Interested in Synta (SNTA) and Its Upcoming Cancer Data     4/17/2015
 Featured Stories
Men With Asthma Less Likely To Develop Lethal Prostate Cancer, Johns Hopkins University Study     5/19/2015
Four Biotech Stocks Advancing New Therapies In The Fight Against Cancer     5/18/2015
Vitamin B May Help Prevent Some Skin Cancers, University of Sydney Study     5/15/2015
Mom Detects Toddler's Eye Cancer By Snapping Photo     5/14/2015
Safety Switches May Redeem Potent CAR T Cancer Therapies     5/8/2015
Study Aims To Uncover Why Cancer Plagues Golden Retrievers     5/8/2015
Is Novartis AG (NVS) An Up-And-Coming Cancer Powerhouse?     5/7/2015
Here's How Aspirin Fights Cancer, University of Minnesota Institute Reveals     5/4/2015
Late Start On Solid Foods Could Up Cancer Risk for Babies, University of Texas Study     5/4/2015
Diet Swap Shows How Junk Food Ups Your Cancer Risk, University of Pittsburgh and Imperial College London Study     5/1/2015
Turmeric May Help Treat Oral Cancers, Emory University Study     4/24/2015
Toxic Drug May Help Battle Colorectal Cancer, MD Anderson Cancer Center Study     4/23/2015
Warning: Too Many Dietary Supplements Ups Your Cancer Risk, University Of Colorado Cancer Center Study     4/23/2015
Chamomile Tea Linked To Lower Thyroid Cancer Risk, Oxford University Study     4/22/2015
Long Term, Regular Aspirin Use May Reduce Cancer Risk, Harvard School of Public Health Study     4/21/2015
 More News
Cellular Biomedicine Group (CBMG) Announces Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program     5/22/2015
Eureka Therapeutics And Boehringer Ingelheim Announce A Collaboration To Identify Next Generation Antibodies For Cancer Treatment     5/22/2015
Northwest Biotherapeutics (NWBO) To Present At New York Academy of Sciences' Conference On Emerging Approaches To Immunotherapy     5/22/2015
Galena Biopharma  (GALE) To Present GALE-401 (Anagrelide Controlled Release) Phase II Clinical Trial Data At The European Hematology Association 20th Congress     5/22/2015
Turning Cancer Against Itself: Major Grant Advances Pioneering Melanoma Therapy At NeoStem, Inc.     5/21/2015
Prima Biomed (PRR.AX) Release: CVAC Shows Overall Survival Benefit In Second Remission Ovarian Cancer In Phase II Study     5/19/2015
BioNTech, Genmab A/S (GEN.CO) Forge $15 Million Immuno-Oncology Pact     5/19/2015
Microlin Bio Announces Issuance Of Thirty Seven Additional Patents For The Use Of Microrna In Cancer Treatment And Diagnosis     5/19/2015
Kura Oncology Release: First Patient Dosed In Phase II Study Of Tipifarnib In Advanced Cancers With HRAS Mutations     5/18/2015
XBiotech USA (XBIT) Secures Approval From Data Safety Monitoring Board To Continue Phase III Registration Study In Europe For Its Novel Cancer Immunotherapy     5/18/2015
Data From TOLMAR Pharmaceuticals Demonstrate ELIGARD Consistently Suppresses Serum Testosterone Levels In Patients With Advanced Prostate Cancer     5/18/2015
Portola Pharmaceuticals, Inc. Announces Upcoming Data Presentation On Dual Kinase Inhibitor Cerdulatinib At ASCO Annual Meeting     5/18/2015
Prometheus Laboratories Inc. Release: New Data Show Proleukin (aldesleukin) Improves Patient Outcomes As First-Line Therapy For The Treatment Of Patients With Metastatic Melanoma Or Metastatic Renal Cell Carcinoma     5/15/2015
Asterias Biotherapeutics Announces Availability Of Abstract With Phase 2 Clinical Data On Cancer Vaccine AST-VAC1 In Acute Myelogenous Leukemia (AML)     5/14/2015
Novogen Limited (NVGN) Release: Anisina Confirmed As Effective Anti-Cancer Agent In Animal Studies     5/14/2015